+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Oropharyngeal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Oropharyngeal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
From
Retinal Vein Occlusion Market Report and Forecast 2024-2032 - Product Thumbnail Image

Retinal Vein Occlusion Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
From
From
Healthcare Services Market Report 2025 - Product Thumbnail Image

Healthcare Services Market Report 2025

  • Report
  • April 2025
  • 500 Pages
  • Global
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator